title: The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
authors.forename: B
authors.initials: B
authors.lastname: Woggon
authors.forename: M
authors.initials: M
authors.lastname: Linden
authors.forename: H
authors.initials: H
authors.lastname: Beckmann
authors.forename: E
authors.initials: E
authors.lastname: Krebs
authors.forename: B
authors.initials: B
authors.lastname: Küfferle
authors.forename: B
authors.initials: B
authors.lastname: Müller-Oerlinghausen
authors.forename: B
authors.initials: B
authors.lastname: Pflug
authors.forename: H W
authors.initials: HW
authors.lastname: Schied
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003984:Dibenzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012107:Research Design; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003984:Dibenzazepines; C041528:fluperlapine; D006220:Haloperidol